Company sells units of common shares, 18-month warrants at C$0.16 each
By Devika Patel
Knoxville, Tenn., April 10 - Critical Outcome Technologies Inc. said it settled a C$1 million second tranche of a C$1.5 million non-brokered private placement of units. The company raised C$500,000 on March 26.
The company has so far sold a total of 9,375,000 units of one common share and one warrant at C$0.16 per unit. It sold 3,125,000 units in the first tranche and 6.25 million units at that price in the second.
The warrants are each exercisable at C$0.30 for 18 months. The strike price reflects a 20% premium to the March 23 closing share price of C$0.25.
"We are very pleased to have strengthened our balance sheet by completing this part of our private placement initiative," board chairman John Drake said of the financing in a press release.
"These funds enable us to continue to move forward expeditiously in completing final experiments for our lead oncology compound, COTI-2, and preparing our investigational new drug submission to the United States Food and Drug Administration."
Based in London, Ont., Critical helps deliver new drug therapies.
| Issuer: | Critical Outcome Technologies Inc.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | C$1.5 million
|
| Units: | 9,375,000
|
| Price: | C$0.16
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | 18 months
|
| Warrant strike price: | C$0.30
|
| Agent: | Non-brokered
|
| Settlement date: | March 26 (for C$500,000), April 10 (for C$1 million)
|
| Stock symbol: | TSX Venture: COT
|
| Stock price: | C$0.25 at close March 23
|
| Market capitalization: | C$13.27 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
